Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. - Wikidata - awgldk - TriplyDB

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.

http://www.wikidata.org/entity/Q37225731

about

Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis IVF and breast cancer: a systematic review and meta-analysis Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility.Female infertility, infertility-associated diagnoses, and comorbidities: a review.Fertility drugs, reproductive strategies and ovarian cancer risk.In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services.Female Reproductive Factors and Differentiated Thyroid Cancer.Female infertility.Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome).Fertility drugs and the risk of breast and gynecologic cancers.Preserving fertility in young patients with endometrial cancer: current perspectives.Fertility drug use and risk of ovarian tumors: a debated clinical challenge.Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort.Risk of breast cancer following fertility treatment--a registry based cohort study of parous women in Norway.Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2).Cancer risk among parous women following assisted reproductive technology.Effects of fertility drugs on cancers other than breast and gynecologic malignancies.Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort.Long-term relationship of ovulation-stimulating drugs to breast cancer risk.Does ovulation induction increase the risk of gynecological cancer?Long-term complications of assisted reproductive technologies.Breast cancer and fertility.Evidence-based lifestyle and pharmacological management of infertility in women with polycystic ovary syndrome.Breast cancer risk after exposure to fertility drugs.Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers.The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up.Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study.Melanoma risk after ovarian stimulation for in vitro fertilization.State of the evidence 2017: an update on the connection between breast cancer and the environment Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer.Aromatase inhibitor use during ovarian stimulation suppresses growth of uterine endometrial cancer in xenograft mouse model.Long-term effects of repeated superovulation on the uterus and mammary gland in rhesus monkeys.Safety of clomiphene citrate: a literature review.Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study.

P2860

Q24200437-63534E0E-2594-4F30-AB91-A2A3E2EFB218 Q28083257-2EDCC24B-99D4-4D92-BC21-0C9C9EC8D988 Q28281796-26E863DE-896C-4424-8BEA-8947220B35B6 Q28295207-A5EAFBA4-9F1B-4284-8AAA-CDB9F447F140 Q30235061-21B05D18-8789-4849-ACD1-71A53AF8ED24 Q30241736-4253540D-F9E2-414F-8174-2C44830F6EDD Q33608317-DFF943D9-04C2-43CB-8799-F829BF75AEED Q33648309-17B30159-1520-4515-903B-8786BE50B174 Q33715432-2C972587-15A9-4A13-9D09-AC1F49027F78 Q33846768-02EF91F2-74D2-4491-85CB-DD596B60CB86 Q33925579-E7C5054E-388B-4758-B434-BA121A046086 Q33931378-ACEF82B8-F96F-4564-A85A-075A20BD8AE7 Q34005400-91E91004-9659-413E-97AD-6AB1470C0FAE Q34297428-CAAB3FCE-7FE8-4DE6-8D37-F8C443431DFD Q34369162-9321DAA8-EC78-45B6-8A8C-9144EFF80E40 Q34715540-88C0A9E2-CB66-4D78-BAB5-EE41955ABAEB Q35540547-F624523B-8AAF-49C1-AE6B-E14A8689EF83 Q35678708-125AE3C0-1239-465B-954F-13D3DAD1657E Q35865978-EE3C54D5-5577-4C93-93F9-3FF9863EEB1C Q36119348-A1B4C0B6-B6AB-4FB1-B119-1316242FB32C Q37183938-24174D5E-6600-4FDC-B7B5-76A689446DD3 Q37691958-45CE126A-6C81-4FB7-84EC-94A2A6ACD43C Q37703912-2C8E57DB-A748-408D-9853-57B8C84FB152 Q37883367-5DDF55A1-5FF3-4C23-9489-138EB65FCACD Q37991254-217D0036-C956-49E4-AD5E-C006D8A71273 Q38007200-550BD8E5-94FC-4418-8CFC-DA5E00E4F5C2 Q38081240-5CFDC631-FF3E-4F53-8C90-842B408662A1 Q38694178-76B6657C-665D-474E-97FC-D31FBD8871F2 Q38967638-54663339-314A-4A45-BE01-D79D21E7D08A Q39008963-88BB6018-E39E-4105-B55F-45FCA594BB57 Q41286527-13C209B1-21FC-4CE7-A194-EF49ADBD2D43 Q41595188-5AF97150-7541-4929-8B08-8F09822857FD Q43427604-06F469DB-D0E4-4B91-A30D-E9A4CC157E13 Q47180421-C6F0CF8A-9332-42A0-9D3F-B1DC0089A649 Q47881572-A9B2D202-ADB7-4FCA-BD4F-274052CC31C1 Q49844348-3B9CD383-1076-4114-908B-A43305529FC3 Q50550240-24C22159-EB0A-4228-8355-7583A411AA91

P2860

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.

http://www.wikidata.org/entity/Q37225731

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.

@en

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.

@nl

type

label

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.

@en

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.

@nl

prefLabel

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.

@en

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.

@nl

P1433

Q37225731-468B1162-8D9A-4A1E-9775-521E4846C20C

P1476

Q37225731-B8AA3F91-7969-4F75-BB74-0C1837C11433

P2093

Q37225731-2271E4BE-1194-4699-9B52-B23AF95E33D6

Q37225731-30149F57-23B6-46F9-949E-F61419ED0FDB

Q37225731-53ACFC64-2518-4B30-ACC5-E3E9278A9DD0

Q37225731-621BAE14-95E9-4BCB-953B-EC94518D65C6

Q37225731-802DA018-F4B4-4E0D-9694-79CB1639D7E9

Q37225731-9E3D1306-3FB7-4EFF-B024-6278E104D3F6

Q37225731-9E4D7DC7-3EFC-43E9-B5E6-16A0DEB8F1D8

Q37225731-DDA1AEE7-E7C3-4295-8943-445BA9C79F1C

Q37225731-DE84F1F7-6A12-4E53-9D4F-3330ED33B4FB

P2860

Q37225731-05AF4276-63BF-42B3-8551-6664619E7C18

Q37225731-0A25C531-2DD2-496B-BA63-774017F0164E

Q37225731-0C491FCA-B071-47C8-B617-B308087ED962

Q37225731-251ED577-5DBD-4CF7-A70C-C56708C8F28C

Q37225731-505D9EAE-42AB-4C4D-9B09-A8E06C49E6C7

Q37225731-66D72284-B101-480D-BDCC-312D36CBE52F

Q37225731-6B30F512-4339-40F1-97DE-929BDC74B541

Q37225731-8DC780BF-9CFA-47E0-AADC-31B1A21ADA4A

Q37225731-98A40AF9-A454-4F3E-A6D8-914BAF56AD1D

Q37225731-9F5AA47D-6337-4A7F-A6B1-E6516FF7DF78

P2888

Q37225731-4754C182-B468-407D-8AFC-534394D1864D

P304

Q37225731-78352C1B-9C22-43CD-B034-85A84A1C5026

P31

Q37225731-0EBE96BA-13A3-4D44-AE03-0058D9B086B8

P356

Q37225731-02C0261A-1DC6-45F8-B2F8-1C675B8D8D32

P407

Q37225731-814D1FB0-D9DF-46C9-ADCF-29341E620E33

P433

Q37225731-D2A8E482-27B1-4C54-BB70-BB67E2D70195

P478

Q37225731-047FD3A2-1D2D-45DC-9F29-C750AC9021B6

P50

Q37225731-63693C5D-545E-4564-ABBA-0FF809A523D9

P577

Q37225731-C73D6611-E534-4980-AD6E-D704265EB8C5

P5875

Q37225731-16555E8E-587C-4277-B235-D1DD37C4586B

P698

Q37225731-9FB4A8C6-2FDC-4D5B-8116-3F8165168EB9

P932

Q37225731-4A77355F-097F-4489-8A29-3B9B452A7BE7

P356

P1433

British Journal of Cancer

P1476

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort

@en

P2093

A B MacLean

http://www.w3.org/2001/XMLSchema#string

C Overton

http://www.w3.org/2001/XMLSchema#string

D Mayer

http://www.w3.org/2001/XMLSchema#string

I dos Santos Silva

http://www.w3.org/2001/XMLSchema#string

J Nieto

http://www.w3.org/2001/XMLSchema#string

M Davies

http://www.w3.org/2001/XMLSchema#string

P A Wark

http://www.w3.org/2001/XMLSchema#string

P Hardiman

http://www.w3.org/2001/XMLSchema#string

V Little

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies

Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies.

Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study.

Risk of cancer after use of fertility drugs with in-vitro fertilisation.

Breast and ovarian cancer incidence after infertility and in vitro fertilisation.

Follicular stimulation for high tech pregnancies: are we playing it safe?

Deprivation: explaining differences in mortality between Scotland and England and Wales.

Cancer risk after exposure to treatments for ovulation induction.

Cancer incidence in a cohort of infertile women.

Cancer incidence following treatment for infertility at a clinic in the UK.

P2888

P304

1824-1831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605086

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Valerie McCormack

P577

2009-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24421711

http://www.w3.org/2001/XMLSchema#string

P698

19436296

http://www.w3.org/2001/XMLSchema#string

P932

2695698

http://www.w3.org/2001/XMLSchema#string